Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
J Clin Med. 2020 Nov 16;9(11):3682. doi: 10.3390/jcm9113682.
J Clin Med. 2020.
PMID: 33207828
Free PMC article.
The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease.
Maibach HT, Brownstein MJ, Hersch SM, Anderson KE, Itzkowitz DE, Damiano EM, Simon NG.
Maibach HT, et al. Among authors: itzkowitz de.
J Pers Med. 2022 Sep 22;12(10):1561. doi: 10.3390/jpm12101561.
J Pers Med. 2022.
PMID: 36294700
Free PMC article.
Item in Clipboard
A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitment.
Difede J, McAleavey AA, Emrich M, Jick A, Ovalles A, Wyka K, Spielman L, Olden M, Peskin M, Becket-Davenport C, Rubenstein A, Brownstein MJ, Damiano E, Itzkowitz D, Lu SF, Needell NJ, Kocsis JH, Gordon-Elliott JS, Simon NG.
Difede J, et al.
Contemp Clin Trials Commun. 2023 Mar 17;33:101116. doi: 10.1016/j.conctc.2023.101116. eCollection 2023 Jun.
Contemp Clin Trials Commun. 2023.
PMID: 37008794
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.